Philipp T, Zschierdrich H, Distler A
Klin Wochenschr. 1977 Sep 15;55(18):917-9. doi: 10.1007/BF01478829.
In 7 hypertensive patients with renal artery stenosis and in 1 patient with hypertension and unilateral pyelonephritic nephrophthisi the influence of the angiotensin II antagonist, saralasin on systemic hemodynamics was studied. In the patients with normal renin infusion of saralasin produced an increase in total peripheral resistance, in patients with elevated renin a decrease in peripheral resistance was observed. In 3 patients who had extremely high renin levels while under sodium saralasin produced a dangerous drop in blood pressure concomitant with a marked decrease in cardiac output and in central venous pressure, heart rate remained unchanged or increased just slightly. The findings suggest that in patients with high plasma renin peripheral resistance, venous tone, venous retrun, and cardiac output are to a large extent controlled by circulating angiotensin II.
对7例肾动脉狭窄的高血压患者以及1例高血压合并单侧肾盂肾炎性肾痨患者,研究了血管紧张素II拮抗剂沙拉新对全身血流动力学的影响。在肾素水平正常的患者中,输注沙拉新可使总外周阻力增加;在肾素水平升高的患者中,则观察到外周阻力降低。在3例肾素水平极高的患者中,在限钠情况下输注沙拉新导致血压危险下降,同时心输出量和中心静脉压显著降低,心率保持不变或仅略有增加。这些发现表明,在血浆肾素水平高的患者中,外周阻力、静脉张力、静脉回流量和心输出量在很大程度上受循环中的血管紧张素II控制。